TrialJournal of genetic counseling2022

A qualitative study of unaffected ATM and CHEK2 carriers: How participants make meaning of 'moderate risk' genetic results in a population breast cancer screening trial.

Jennifer Elyse James et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.